Cefmenoxime
| Code | Size | Price |
|---|
| TAR-T1190L-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Cefmenoxime is a cephalosporin antibiotic administered intravenously or intramuscularly. It is an effective inhibitor of Enterobacteriaceae and is resistant to beta-lactamase-initiated hydrolysis. It is active against most common gram-positive and gram-negative microorganisms.
CAS:
65085-01-0
Formula:
C16H17N9O5S3
Molecular Weight:
511.55
Purity:
0.98
SMILES:
[H][C@]12SCC(CSc3nnnn3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)c1csc(N)n1)C(O)=O
References
1. Eicken A, Sch?ber JG, Roos R, Machka K. Cerebrospinal fluid penetration of cefmenoxime in children with bacterial meningitis. Infection. 1991 Nov-Dec;19(6):406-8. PubMed PMID: 1816111.
2. Washida H, Tsugaya M, Hirao N, Sakagami H, Iwase Y. [Pharmacokinetic study of cefmenoxime concerning its transfer into tissues]. Jpn J Antibiot. 1985 Jun;38(6):1648-53. Japanese. PubMed PMID: 3862883.
3. Stamm JM, Girolami RL, Shipkowitz NL, Bower RR. Antimicrobial activity of cefmenoxime (SCE-1365). Antimicrob Agents Chemother. 1981 Mar;19(3):454-60. PubMed PMID: 6264846; PubMed Central PMCID: PMC181453.
4. Kita Y, Itakura K, Tsuchiya K, Imada A. Pharmacokinetics of SCE-1141, a stereoisomer of cefmenoxime, in rats. J Antimicrob Chemother. 1986 Feb;17(2):205-13. PubMed PMID: 3457784.